Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, McCourt Marion, holds the title of EVP Commercial at REGENERON PHARMACEUTICALS, INC..
On 2026-11-16, the insider transacted 566 shares.The shares were transacted at a weighted average price of $960.25 per share, resulting in a total market-relevant value of $544K.
McCourt Marion (EVP Commercial) sold $544K of $REGN
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.